A novel pathway for the management of hypertension for hospitalized patients

Critical Pathways in Cardiology

Volumn 6, Issue 4, 2007, Pages 150-160

  Herzog, Eyal ^a   Frankenberger, Olivier ^a   Aziz, Emad ^a   Bangalore, Sripal ^a   Balaram, Sandhya ^a   Nasrallah, E John ^a   Cortell, Stanley ^a   Messerli, Franz H ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Clinical pathway; Emergency hypertension; Hypertension; Hypertensive urgency; In hospital hypertension

Indexed keywords

ALDOSTERONE RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLONIDINE; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESMOLOL; GLYCERYL TRINITRATE; LABETALOL; LOOP DIURETIC AGENT; METOPROLOL SUCCINATE; NICARDIPINE; RAS BLOCKER; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ADD ON THERAPY; AORTA DISSECTION; ARTICLE; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; NEUROLOGIC DISEASE; PATIENT CARE; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CRITICAL PATHWAYS; HOSPITALIZATION; HUMANS; HYPERTENSION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 37449025850     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e318160c3a7     Document Type: Article

References (23)

1. Chobanian AV, Bakris GL, Henry R, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2562.
2. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology. J Hypertens. 2007;25:1105-1187.
3. National High Blood Pressure Education Program. Working Group on High Blood Pressure in Pregnancy: report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy [supplement]. Am J Obstet Gynecol. 2000;183:S1-S22.
4. Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in pregnancy. Crit Care Med. 2005;33(suppl):S307-S312.
5. Adams HP, Zoppo G, Alberts M, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke. 2007;38:1655-1711
6. Rosendroff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115:2761-2788.
7. Tsai TT, Nienaber CA, Eagle KA. Acute aortic syndromes. Circulation. 2005;112:3802-3813.
8. Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897-903.
9. Phillips SJ. Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension. 1994;23:131-136.
10. The National Institute of Neurological Disorder and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1857.
11. Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke. 1998;29:1504-1509.
12. Messerli, Franz H. Cerebroprotection by hypertension in ischemic stroke: the crumbling of a hypothesis. Circulation. 2007;115:2907-2908.
13. Schrader J, Luders S, Kulschewski A, et al. Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. Stroke. 2003;34:1699-1703.
14. Herzog E, Frankenberger O, Pierce W, et al. The SELF. Pathway for the management of Syncope. Crit Pathways Cardiol. 2006;5:173-178.
15. Herzog E, Saint-Jacques H, Rozanski A. The PAIN pathway as a tool to bridge the gap between evidence and management of acute coronary syndrome. Crit Pathways Cardiol. 2004;3:20-24.
16. Frazier CG, Shah SH, Armstrong PW, et al. SYMPHONY and the second SYMPHONY Investigators. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observation from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials. Am Heart J. 2005;150:1260-1267.
17. Boersma E, Pieper KS, Steyerberg EW, et al. ., the PURSUIT Investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segments elevation: results from an international trial of 9461 patients. Circulation. 2000;101:2557-2567.
18. Herzog E, Varley C, Kukin M. Pathway for the management of acute heart failure. Crit Pathways Cardiol. 2005;4:37-42.
19. Adams KF Jr, Fonarow GC, Emerman CL, et al. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensation Heart Failure National Registry (ADHERE.) Am Heart J. 2005;149:209-216.
20. Elliott WJ. Clinical features and management of selected hypertensive emergencies. J Clin Hypertens. 2004;6:587-592.
21. Onusko E. Diagnosing secondary hypertension. Am Fam Physician. 2003;67:67-74.
22. Silverberg DS, Oksenberg A. Essential and secondary hypertension and sleep-disordered breathing: a unifying hypothesis. J Hum Hypertens. 1996;157:2413-2446.
23. Gordon RD. Mineralocorticoid hypertension. Lancet. 1994;344:240-243.